KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) EPS (Weighted Average and Diluted) (2016 - 2026)

Globus Medical filings provide 15 years of EPS (Weighted Average and Diluted) readings, the most recent being $1.02 for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 436.84% to $1.02 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.93, a 424.0% increase, with the full-year FY2025 number at $3.92, up 422.67% from a year prior.
  • EPS (Weighted Average and Diluted) hit $1.02 in Q4 2025 for Globus Medical, up from $0.88 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $1.49 in Q2 2025 to a low of -$0.05 in Q1 2024.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.44 (2021), compared with a mean of $0.46.
  • The widest YoY moves for EPS (Weighted Average and Diluted): up 3700.0% in 2024, down 110.42% in 2024.
  • Globus Medical's EPS (Weighted Average and Diluted) stood at $0.14 in 2021, then soared by 250.0% to $0.49 in 2022, then crashed by 81.63% to $0.09 in 2023, then skyrocketed by 111.11% to $0.19 in 2024, then surged by 436.84% to $1.02 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $1.02 (Q4 2025), $0.88 (Q3 2025), and $1.49 (Q2 2025) per Business Quant data.